Ex-Genzyme head Meeker to lead Flagship drug startup KSQ

Since leaving his longtime post as head of Cambridge rare disease giant Sanofi Genzyme, David Meeker has been looking to join a company that, as he put it in an interview, “has the ability to make a difference.” Meeker, who departed Genzyme in June after more than 23 years, didn't have to look very long — or far. On Monday, KSQ Therapeutics, a cancer drug startup that is backed by Flagship Pioneering and located about a mile from the Genzyme building in Kendall Square, announced that it had…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news